Hospital infection caused by multi-drug-resistant Mycobacterium tuberculosis
Watanabe, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 3): 117-121
2003
ISSN/ISBN: 0047-1852 PMID: 12717957 Document Number: 556832
Document emailed within 1 workday
Related Documents
Okumura, M.; Yoshiyama, T.; Ogata, H.; Morimoto, K.; Kokuto, H.; Kurashima, A.; Kudoh, S. 2011: Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital Kekkaku: 86(11): 863-868Sulistijawati, R.Sri.; Icksan, A.Ghanie.; Lolong, D.Bisara.; Nurwidya, F. 2019: Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey Acta Medica 62(1): 24-29
García Vázquez, E.; Esteban, J.; de Górgolas, M.; Fernández Guerrero, M.L. 1999: Infection by resistant Mycobacterium tuberculosis in a hospital population. a longitudinal study of incidental cases at the Fundación Jiménez Díaz Revista Clinica Espanola 199(9): 564-568
Foroumadi, A.; Soltani, F.; Moshafi, M.H. 2002: Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis Bollettino Chimico Farmaceutico 141(5): 394-396
Datta, S.; Wattal, C.; Goel, N.; Oberoi, J.K.; Raveendran, R.; Prasad, K.J. 2012: A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital Indian Journal of Medical Research 135(6): 907-912
Katalinić-Janković, V.; Obrovac, M. 2004: Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 58(4): 323-328
Firsova, V.A.; Rusakova, L.I.; Grigor'eva, Z.P.; Ryzhova, A.P.; Iatskova, T.V.; Poluéktova, F.G. 2001: Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis Problemy Tuberkuleza 1: 28-30
Zhukova, M.P. 1998: Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates Problemy Tuberkuleza 4: 4-5
Paramasivan, C.N.; Venkataraman, P.; Herbert, D. 1997: Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis Microbios 89: 360-361
Mahmood, A. 2001: Multi-drug resistant tuberculosis Jpma. Journal of the Pakistan Medical Association 51(5): 204-205
Foroumadi, A.; Soltani, F. 2003: Antituberculosis agents. IX. in vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates Bollettino Chimico Farmaceutico 142(6): 248-250
Alrajhi, A.A. 2002: Drug-resistant Mycobacterium tuberculosis in Saudi Arabia: how little we know Annals of Saudi Medicine 22(3-4): 141-142
Okumura, M.; Kudoh, S. 2011: Treatment of multi-drug resistant tuberculosis Nihon Rinsho. Japanese Journal of Clinical Medicine 69(8): 1394-1399
Dheda, K. 2009: Extensively drug-resistant Mycobacterium tuberculosis: what are these bugs up to in India? Indian Journal of Medical Research 130(4): 357-358
Butt, T.; Ahmad, R.N.; Kazmi, S.Y.; Rafi, N. 2004: Multi-drug resistant tuberculosis in Northern Pakistan Jpma. Journal of the Pakistan Medical Association 54(9): 469-472
Saxena, A.; Mukherjee, U.; Dua, A.; Lal, R. 2012: India losing battle against multi drug resistant tuberculosis Indian Journal of Microbiology 52(4): 713
Post, F.A.; Grint, D.; Werlinrud, A.M.; Panteleev, A.; Riekstina, V.; Malashenkov, E.A.; Skrahina, A.; Duiculescu, D.; Podlekareva, D.; Karpov, I.; Bondarenko, V.; Chentsova, N.; Lundgren, J.; Mocroft, A.; Kirk, O.; Miro, J.M.; Chentsova, N.; Duiculescu, D.; Furrer, H.; Girardi, E.; Bruyand, M.; Losso, M.H.; Lundgren, J.D.; Panteleev, A.; Miller, R.; Miro, J.M.; Obel, N.; Post, F.; Riekstina, V.; Skrahin, A.; Toibaro, J.J.; Podlekareva, D.; Kirk, O.; Mocroft, A.; Kjær, J.; Ellefson, M.; Lundgren, J.D.; Kirk, O.; Mocroft, A.; Kjær, J.; Matthews, C.; Nielsen, J.; Fischer, A.; Bojesen, A.; Karpov, I.; Vasilenko, A.; Skrahina, E.; Skrahin, A.; Mitsura, V.; Kozorez, E.; Ruzanov, D.; Bondarenko, V.; Suetnov, O.; Paduto, D.; Riekstina, V.; Aldin 2014: Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe Journal of Infection 68(3): 259-263
Lee, A.S.G.; Tang, L.L.H.; Lim, I.H.K.; Wong, S.Yew. 2002: Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(1): 48-51
Hong, C.-Y.; Wang, F.; Gui, J.; Liu, X.-l. 2012: Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide Zhonghua Yu Fang Yi Xue Za Zhi 46(5): 436-439
Mizutani, H.; Horiba, M.; Shindoh, J.; Kimura, T.; Son, M.; Wakahara, K. 2001: Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism Kekkaku: 76(10): 667-672